Global Gastrointestinal Stents Market Set to Surge to USD 815.34 Million by 2033

The global gastrointestinal stents market is experiencing robust growth, with the latest industry analysis projecting it to reach USD 815.34 million by 2033, up from USD 476.72 million in 2023. This surge represents a compound annual growth rate (CAGR) of 5.51%, highlighting the increasing significance of gastrointestinal stents in addressing complex digestive disorders.

Gastrointestinal stents have become a critical component of modern healthcare, providing essential, minimally invasive solutions for patients suffering from gastrointestinal (GI) obstructions, strictures, cancers, and other conditions. As innovations in medical technology continue to evolve, the development of more efficient and effective stent devices is transforming patient care and enhancing treatment outcomes worldwide. These advancements not only improve the efficacy of GI treatments but also broaden the scope of therapeutic options available to patients and healthcare providers alike.

Driving Factors in Market Growth: Innovation and Aging Population

Several factors contribute to the growth of the global gastrointestinal stent market. Technological breakthroughs in stent design and materials have enabled the creation of devices that better address patient needs while enhancing procedural safety and effectiveness. Additionally, the global aging population and rising prevalence of GI disorders contribute significantly to increased demand for these medical devices. Gastrointestinal stents are proving indispensable in managing various GI disorders, improving patient quality of life, and offering healthcare providers reliable, patient-friendly solutions.

Future Outlook: An Indispensable Tool in Patient-Centric Care

Experts predict that the upward trajectory of the gastrointestinal stents market will continue over the next decade, fueled by ongoing advancements and a growing emphasis on patient-centered care. As healthcare systems worldwide prioritize minimally invasive solutions, the adoption of gastrointestinal stents is expected to further solidify their role in medical practice, providing patients with safer, more effective treatment options.

With the demand for gastrointestinal stents expected to rise, these devices remain pivotal in improving patient outcomes, enhancing treatment standards, and supporting the shift toward less invasive healthcare solutions. As a result, gastrointestinal stents will continue to be a critical tool for healthcare providers and an essential component of global healthcare innovation.

Surge in Market Demand: Explore Comprehensive Trends and Analysis in Our Full Report!

Key Takeaways:

• Due to the increasing prevalence of chronic liver disease and the increase in the number of surgical procedures for the treatment of biliary diseases, the biliary stents segment is likely to account for the largest gastrointestinal stents market share as per the product type.
• Based on material, self-expanding metal stents are expected to lead the market. The same can be credited to benefits such as ease of insertion, a lower possibility of dislodgment or migration, and longer patency.
• During the forecast period, the gastrointestinal cancers segment is anticipated to have the highest CAGR attributed to the increased prevalence and incidence, thereby positively impacting the gastrointestinal stents market trends.
• The hospitals and clinics segment will be at the forefront of the market, owing to many endoscopic retrograde cholangiopancreatographies (ERCP) and percutaneous transhepatic cholangiography (PTC) procedures performed in hospitals for various disease indications.

“In terms of market share and revenue, North America is predicted to dominate the gastrointestinal/GI stent market and will maintain its dominance throughout the forecast period on account of a sophisticated level of healthcare facilities, a rising geriatric population, high incidence of gastrointestinal diseases, favorable reimbursement scenario, and presence of key market players such as C.R. Bard (US), and Becton, Boston Scientific Corporation (US), Dickinson and Company.” opines an FMI researcher.

Competitive Landscape:

Among the prominent players in the GI, stents market are

• Boston Scientific Corporation
• Hobbs Medical Inc.
• Taewoong Medical
• Micro–Tech (Nanjing) Co., Ltd.
• Olympus Corporation
• Merit Medical Systems
• Qualimed
• Medtronic
• Conmed Corporation
• Terumo Corporation
• Johnson & Johnson Services, Inc.,

The gastrointestinal stent market is moderately competitive, with numerous gastrointestinal stents market opportunities. In addition, the increasing prevalence of diseases associated with gastrointestinal tract stent placement is driving up demand for gastrointestinal stents.

As a result, several global corporations are implementing various strategies to reach out to emerging economies such as product launches, mergers, acquisitions, partnerships, collaborations, etc.

Some of the recent developments in the gastrointestinal stents market are:

• Cook Medical worked with Taewoong Medical to expand patient treatment options by distributing a variety of Taewoong’s stents in the United States. The Niti-STM Through the Scope (TTS) Esophageal Stent, the flagship product of the South Korean company’s Niti-S Self-Expandable line of the metal gastrointestinal stent, is included in this distribution collaboration.
• Olympus has proposed a couple of self-expanding metal stents (SEMS) to be used as palliative measures in patients with a short life expectancy or who have malignant colonic or duodenal obstruction.

Key Market Segments Covered in Gastrointestinal Stent Industry Research:

By Product:

• Biliary Stents
• Duodenal Stents
• Colonic Stents
• Pancreatic Stents
• Esophageal Stents

By Material:

• Self–Expanding Metal Stents
• Plastic Stents

By Application:

• Biliary Diseases
• Irritable Bowel Syndrome
• Gastrointestinal Cancers
• Colorectal Cancer
• Stomach Cancer
• Esophageal Cancer
• Pancreatic Cancer

By End User:

• Hospitals and Clinics
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube